ERBB2 and gastric cancer: In fact, findings using gastric cancer cell lines showed that HER2-mediated PD-L1 expression is via the PI3K-AKT-mTOR pathway (Figure 8h), and inhibition of the PI3K–AKT–mTOR pathway decreases PD-L1 expression [36].